We report here results ofa worldwide survey of apolipoprotein (apo) A1 and B measurements. A lyophilized pool of human serum was developed for the survey to test its suitability as a candidate Reference Material. Seventy-five laboratories from 18 countries responded to invitations to participate. Using several methods, they evaluated the mass concentration of apo A1 and B in the proposed Reference Material. The bias between laboratories and between analytical methods was then characterized. Fifty-five laboratories reported results before the deadline on measurement of at least one apolipoprotein by one method. Variation in apo A1 and B among collaborators constituted the largest source of error in the study (68% of the total variation for apo A1, 73% for apo B). Variation among method means was not significant for apo A1, but for apo B it constituted 20% of the total variation. Differences due to vials or in replicate measurements within vials were found to constitute 6% or less of the total variability. Within-laboratory, among-vial, and amongreplicate CV values were <5% for the study. These results suggest that future standardization efforts can be successful. problems of methodology and materials (1, 2). Then the Centers for Disease Control (CDC) was invited to plan and carry out a worldwide survey of apo A1 and B measurements. CDC developed a lyophilized serum pool prepared from "freshly" collected human serum for use in the survey, to test its suitability as a candidateReference Material.
problems of methodology and materials (1, 2). Then the Centers for Disease Control (CDC) was invited to plan and carry out a worldwide survey of apo A1 and B measurements. CDC developed a lyophilized serum pool prepared from "freshly" collected human serum for use in the survey, to test its suitability as a candidateReference Material.
Seventy-five
laboratories from 18 countries responded to published invitations to join the survey.
The study design called for the international participants, using routine or research methods, to analyze the proposed Reference Material for mass concentration, in grams per liter, of apo A1 and B, after which the bias between laboratories and between analytical methods would be characterized.
Such bias would serve to document the extent of methodological agreement that exists between the participating laboratories and the degree of need for common apolipoprotein standards.
It would also indicate to each participanta relative measure of the respectively assayed concentration.
The survey design and data analysis were performed in collaboration with the JIJIS Biometrics Subcommittee.
Materials and Methods

Proposed Serum Pool Reference Material
A lyophilized apolipoprotein serum pool of 9500 vials, each containing 1 mL, was prepared as a proposed ape A1 and B Reference Material. CDC staff members collected serum for the pool from individual donors, which was promptly processed by a procedure that has been found satisfactory for preparing stable pools of high-density lipoprotein(HDL) cholesterol serum (3). Each of the 90 individually collected units and the final serum poo1 were tested for free glycerol, extent of peroxidation, and HDL-cholesterol solubility with ionic strength by procedures established at CDC. Only one of the 90 was found to contain increased amounts of peroxidation products; none had abnormally high concentrations of free glycerol. All the sera tested negative for hepatitis. Table 1 gives the analyte characteristics of the remaining 89. Values obtained with a battery of 20 clinical tests were within the expected normal ranges established at CDC and were unchanged 10 months later. Hemoglobin in the lyophilized serum poo1 was high, 0.21 g/L. The serum units were combined into one pool, maintained at 4#{176}C overnight, then siphoned to separate chylomicrons and subjected to particle and bacteriological filtration through seven consecutive glycerol-free filters of decreasing pore sizes. The 1.0-mL aliquots for lyophilization were dispensed into sterile 2.5-mL Wheaton vials with a precision reflected by a CV of 0.3%, as determined by weighing. The contents of all vials were lyophilized simultaneously on one machine, so freeze-drying conditions would be uniform. The vials were then stored at -20 #{176}C until they were distributed by airmail.
Analyses of samples of the proposed reference apolipoprotein serum pool showed that lyophilization and reconstitution per se caused damage resulting in about a 14% decrease it was again mixed by gentle and thorough swirljig on a blood-mixing wheel or similar device for 5 miii. For specified cutoff date. Ten values from two laboratories using ultracentrifuge assays were not included because of too-few observations.To examine the data for extreme observations, we evaluated each collaborator's mean concentration vs the .. 
Results
A total of 476 ape A1 values from 55 laboratories and 596 ape B values from 51 laboratories were available for analysis. An overall nested analysis of variance was done for each protein for the selected factors (area, methods, laboratories, vials, and error), and the results are shown in Table 3 . For ape A1, the variation among the three areas considered constituted 13.5% of the total variation. This component was negligible (approximately zero) for ape B. The variation among methods was negligible for ape A1 but accounted for about a fifth of the total variation for ape B. Variation in results among laboratories was by far the largest variance component for both proteins, contributing about two-thirds of the total variation. Variability due to vials and measurements within vials accounted for only about one-twentieth of the total differences seen. The within-vial coefficient of variation (CV) of replicate measurements was <5% for both proteins. Thus, concentration differences found among laboratories are the most variable factor for both proteins, although concentration differences among methods are considerable for apo B.
Mean ape A1 and B concentrations by area and method are shown in Table 4 . The overall mean concentrations for the three world areas differ significantly for ape A1 (p < .01) but not for ape B (p = .10) at a 5% probability cutoff for significance.
For both proteins, the means for the European measurements are smaller than the North American means. With respect to methods, inspection of the means for ape A1 shows very close agreement among all methods. The EIA and RID means for ape B are practically identical, but the NA mean is considerably greater. The few data received for ELS and RIA prohibit a good comparison with other methods, but these means are also larger relative to EIA and RID. Thus, differences in mean concentration by method are more striking for the ape B, in contrast to the remarkable similarity of the ape A1 results. 
'Analysis of variance indicates significant among-area differences (p <.01).
The overall mean for Europe is 10.3% less than the overall mean for North America.
"Analysis of variance shows no significant among-area differences (p = .10). The overallmean for Europeis 4.4% less than the overall mean for North America. Table 5 shows the variation in protein concentration results within analytical methods. The percentage variation ascribable to among-collaborator sources ranges from 74% (NA, ape A1) to 97% (EIA and RIA, ape B). Thus, for any given method, differences among laboratories account for at least three-fourths of the total variation experienced. ELS shows the greatest among-replicate variation, with a CV of 10%, but the number of measurements is smaller than that for other analyses. The smallest among-replicate CV observed is for the ape A1 as measured by RID. 
Discussion
Apolipeproteins are an integral and controlling constituent of the transport and metabolic functions of the serum lipoproteins (4 (6), receptor sites (7), and disorders of intermediary metabolism involving ape E (8) .
Methodological problems and lack of comparability of results by different methods have been emphasized at conferences on apelipeproteins Heart and vascular atherosclerotic disease is directly related to cholesterol content of ape B low-density and verylow-density lipoproteins and inversely related to cholesterol content of ape A1 high-density lipeprotein (4, 9) . Because much effort is being devoted to research in coronary heart disease and to the development of therapeutic regimens (10, 11), the ape A1 and B were selected for the first efforts These two points are connected and shaded according to laboratory method. The medians of the laboratory means are represented by the two orthogonal lines.
Measurements for both proteins cluster very near the centrality for several participants, but correlation between ape A1 and B is only moderately good (r = 0.65 for this plot). INA measurements from three laboratories appear to be high for ape B as compared with ape A1. Two collaborators had relatively low values for both proteins. The differences in concentration by method were easily seen for ape B. The histograms, together with the tabulation of all data ( Table 5 ), indicate that the grand medians for all laboratory mean values could be the most representative estimates of the concentrations of the apolipoproteins in this proposed serum pool. These values are 1.2 g/L and 0.605 g/L for apo A1 and B, respectively, and are within 3% of the preliminary results for ape A1 and B determined by an RIA method set up at CDC as a tentative point of reference.
The results of this survey suggest that standardization of methods used for measuring apo A1 and B can be successful in the future. Calibration within each laboratory by use of a 
